Table of contents
Despite growing interest in AI within the life sciences supply chain, the industry still struggles to fully understand its capabilities and potential for driving efficiency. To address this, the LogiPharma AI Report 2024 from WBR Insights shares data-driven insights from 100 global life sciences supply chain leaders. The report also features TraceLink President and CEO Shabbir Dahod, who provides expert commentary on the challenges and opportunities AI brings to end-to-end supply chain digitalization and orchestration.
Download the report to see insights from your peers:
- AI has become a key focus for boardrooms, with 51% of supply chain leaders expecting ROI from AI/ML investments within 2-3 years.
- Inventory optimization and supply chain visibility are top priorities for AI investment, enhancing efficiency and empowering workers.
- 44% of companies focus on planning improvements, highlighting the ongoing journey toward digital maturity and process optimization.
- AI adoption aligns with sustainability efforts, with 52% using emissions reporting tools to support greener supply chains and regulatory compliance.
- Disparate systems and data silos, identified by 55% as major challenges, emphasize the need for better integration to improve cold chain management and meet standards.
